Literature DB >> 7731692

K-ras gene mutations in early colorectal cancer ... flat elevated vs polyp-forming cancer....

H Hasegawa1, M Ueda, M Watanabe, T Teramoto, M Mukai, M Kitajima.   

Abstract

K-ras gene mutations in early colorectal cancer were detected by two-step sensitive polymerase chain reaction (PCR) and enzyme digestion method. Early colorectal cancer was classified into flat elevated cancer or polyp-forming cancer according to morphology and presence of adenomatous components. A total of 60 paraffin-embedded tissue specimens from patients with early colorectal cancer were analysed. K-ras codon 12 mutations were detected in 23.3% (7/30) of flat elevated cancer and 63.3% (19/30) of polyp-forming cancer. The incidence of K-ras codon 12 mutations in flat elevated cancer was significantly lower than in polyp-forming cancer (P < 0.01). These data suggested that K-ras gene mutations may be correlated with morphology or clinical features in flat elevated cancer, and that flat elevated cancer may originate from a pathway different from adenoma-carcinoma sequence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731692

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women.

Authors:  K Servomaa; A Kiuru; V M Kosma; P Hirvikoski; T Rytömaa
Journal:  Mol Pathol       Date:  2000-02

3.  Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.

Authors:  A Rashid; M Zahurak; S N Goodman; S R Hamilton
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

4.  Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis.

Authors:  Hiroto Kita; Yuichi Hikichi; Kouki Hikami; Koichi Tsuneyama; Zheng-Guo Cui; Hiroyuki Osawa; Hirohide Ohnishi; Hiroyuki Mutoh; Hiroko Hoshino; Christopher L Bowlus; Hironori Yamamoto; Kentaro Sugano
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

5.  Acquisition of anoikis resistance promotes the emergence of oncogenic K-ras mutations in colorectal cancer cells and stimulates their tumorigenicity in vivo.

Authors:  Mathieu Derouet; Xue Wu; Linda May; Byong Hoon Yoo; Takehiko Sasazuki; Senji Shirasawa; Janusz Rak; Kirill V Rosen
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

6.  Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples.

Authors:  R Ward; N Hawkins; R O'Grady; C Sheehan; T O'Connor; H Impey; N Roberts; C Fuery; A Todd
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

Review 7.  Oncogenes as inducers of tumor angiogenesis.

Authors:  J Rak; J Filmus; G Finkenzeller; S Grugel; D Marmé; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

8.  Infrequent K-ras codon 12 mutation in serrated adenomas of human colorectum.

Authors:  Y Ajioka; H Watanabe; J R Jass; Y Yokota; M Kobayashi; K Nishikura
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

9.  Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms.

Authors:  Hedwig Richter; Premysl Slezak; Axel Walch; Martin Werner; Herbert Braselmann; Edgar Jaramillo; Ake Ost; Ichiro Hirata; Kazuya Takahama; Horst Zitzelsberger
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Specific K-ras2 mutations in human sporadic colorectal adenomas are associated with DNA near-diploid aneuploidy and inhibition of proliferation.

Authors:  W Giaretti; A Rapallo; E Geido; A Sciutto; F Merlo; M Risio; F P Rossini
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.